These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 7957640

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
    Pristupa ZB, Wilson JM, Hoffman BJ, Kish SJ, Niznik HB.
    Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271
    [Abstract] [Full Text] [Related]

  • 23. Thermodynamic analyses of the binding of substrates and uptake inhibitors on the neuronal carrier of dopamine labeled with [3H]GBR 12783 or [3H]mazindol.
    Bonnet JJ, Benmansour S, Costentin J, Parker EM, Cubeddu LX.
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1206-14. PubMed ID: 2141637
    [Abstract] [Full Text] [Related]

  • 24. Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine.
    Kula NS, Baldessarini RJ.
    Neuropharmacology; 1991 Jan; 30(1):89-92. PubMed ID: 2046881
    [Abstract] [Full Text] [Related]

  • 25. Oxygenated analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as potential extended-action cocaine-abuse therapeutic agents.
    Lewis DB, Matecka D, Zhang Y, Hsin LW, Dersch CM, Stafford D, Glowa JR, Rothman RB, Rice KC.
    J Med Chem; 1999 Dec 02; 42(24):5029-42. PubMed ID: 10585212
    [Abstract] [Full Text] [Related]

  • 26. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics.
    Richfield EK.
    Brain Res; 1991 Feb 01; 540(1-2):1-13. PubMed ID: 1829013
    [Abstract] [Full Text] [Related]

  • 27. Thermodynamics of the binding of BTCP (GK 13) and related derivatives on the dopamine neuronal carrier.
    Billaud G, Menard JF, Marcellin N, Kamenka JM, Costentin J, Bonnet JJ.
    Eur J Pharmacol; 1994 Aug 16; 268(3):357-63. PubMed ID: 7805759
    [Abstract] [Full Text] [Related]

  • 28. Characterization of a recombinant human dopamine transporter in multiple cell lines.
    Eshleman AJ, Neve RL, Janowsky A, Neve KA.
    J Pharmacol Exp Ther; 1995 Jul 16; 274(1):276-83. PubMed ID: 7616409
    [Abstract] [Full Text] [Related]

  • 29. Zinc modulation of drug binding, cocaine affinity states, and dopamine uptake on the dopamine uptake complex.
    Richfield EK.
    Mol Pharmacol; 1993 Jan 16; 43(1):100-8. PubMed ID: 8423763
    [Abstract] [Full Text] [Related]

  • 30. A pharmacological comparison of [3H]GBR12935 binding to rodent striatal and kidney homogenates: binding to dopamine transporters?
    Sharif NA, Nunes JL, Kalfayan V, McClelland DL, Rosenkranz RP, Eglen RM, Whiting RL.
    Neurochem Int; 1992 Jul 16; 21(1):69-73. PubMed ID: 1303143
    [Abstract] [Full Text] [Related]

  • 31. Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter.
    Houlihan WJ, Boja JW, Parrino VA, Kopajtic TA, Kuhar MJ.
    J Med Chem; 1996 Dec 06; 39(25):4935-41. PubMed ID: 8960553
    [Abstract] [Full Text] [Related]

  • 32. Development of novel, potent, and selective dopamine reuptake inhibitors through alteration of the piperazine ring of 1-[2-(diphenylmethoxy)ethyl]-and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909).
    Matecka D, Rothman RB, Radesca L, de Costa BR, Dersch CM, Partilla JS, Pert A, Glowa JR, Wojnicki FH, Rice KC.
    J Med Chem; 1996 Nov 22; 39(24):4704-16. PubMed ID: 8941383
    [Abstract] [Full Text] [Related]

  • 33. Highly selective, novel analogs of 4-[2-(diphenylmethoxy)ethyl]- 1-benzylpiperidine for the dopamine transporter: effect of different aromatic substitutions on their affinity and selectivity.
    Dutta AK, Coffey LL, Reith ME.
    J Med Chem; 1997 Jan 03; 40(1):35-43. PubMed ID: 9016326
    [Abstract] [Full Text] [Related]

  • 34. HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes.
    Zhu J, Mactutus CF, Wallace DR, Booze RM.
    J Pharmacol Exp Ther; 2009 Jun 03; 329(3):1071-83. PubMed ID: 19325033
    [Abstract] [Full Text] [Related]

  • 35. Cations affect [3H]mazindol and [3H]WIN 35,428 binding to the human dopamine transporter in a similar fashion.
    Wu Q, Coffey LL, Reith ME.
    J Neurochem; 1997 Sep 03; 69(3):1106-18. PubMed ID: 9282933
    [Abstract] [Full Text] [Related]

  • 36. Recovery of dopamine neuronal transporter but lack of change of its mRNA in substantia nigra after inactivation by a new irreversible inhibitor characterized in vitro and ex vivo in the rat.
    Régo JC, Syringas M, Leblond B, Costentin J, Bonnet JJ.
    Br J Pharmacol; 1999 Sep 03; 128(1):51-60. PubMed ID: 10498834
    [Abstract] [Full Text] [Related]

  • 37. High-affinity [3H]GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system.
    Bonnet JJ, Protais P, Chagraoui A, Costentin J.
    Eur J Pharmacol; 1986 Jul 31; 126(3):211-22. PubMed ID: 3489625
    [Abstract] [Full Text] [Related]

  • 38. O-526, a piperidine analog of GBR 12909, retains high affinity for the dopamine transporter in monkey caudate-putamen.
    Madras BK, Reith ME, Meltzer PC, Dutta AK.
    Eur J Pharmacol; 1994 Apr 15; 267(2):167-73. PubMed ID: 8050478
    [Abstract] [Full Text] [Related]

  • 39. Effects of several cations on the neuronal uptake of dopamine and the specific binding of [3H]GBR 12783: attempts to characterize the Na+ dependence of the neuronal transport of dopamine.
    Amejdki-Chab N, Benmansour S, Costentin J, Bonnet JJ.
    J Neurochem; 1992 Nov 15; 59(5):1795-804. PubMed ID: 1402923
    [Abstract] [Full Text] [Related]

  • 40. Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter.
    Dutta AK, Xu C, Reith ME.
    J Med Chem; 1998 Aug 13; 41(17):3293-7. PubMed ID: 9703474
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.